Disclosure of interest: Dr Rohid Zamani: Nothing to disclose, Dr Daniel McWilliams: nothing to disclose, Dr Sameer Limaye: Nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.04 - STROKE COMPLICATIONS P2566 - ESOC25-2302 CEREBRAL SALT-WASTING SYNDROME IN PATIENTS WITH ACUTE ISCHEMIC STROKE: A NARRATIVE LITERATURE REVIEW Nikolaos Faraklas Perdikouris 1 , Athanasios Vasilopoulos 2 , Athanasios Mitsias 1 , Panayiotis Mitsias 1,3,4 1 School of Medicine, University of Crete, Heraklion, Greece, 2 University Hospital of Lyon, Lyon, France, 3 University Hospital of Heraklion, Heraklion, Greece, 4 Department of Neurology, Henry Ford Hospital, Detroit, United States Background and Aims: Hyponatremia is a common complication of acute stroke and may be the result of inappropriate ADH Secretion (SIADH) or cerebral salt-wasting syndrome (CSWS)
aureus with KL1, followed by washing before macrophage infection, did not enhance antibiotic-mediated killing (Extended Data Fig
Methods: The ETIS (Endovascular Treatment in Ischemic Stroke) registry is a prospective, observational study across 21 French EVT centers
Partnering with the right medical provider is the most important decision you will make in optimizing the effectiveness and safety of your peptide therapy
Educating the patient on how NSAID therapy should be conducted and combating side effects arising from improper, addictive therapy is an important aspect for maintaining and restoring health
